IP Library Granted Patent US 10,124,036
Granted Patent B2
US 10,124,036 · App. 14/738,627 · Granted Nov 13, 2018

Liquid nutritional formula for tyrosinemia patients

Inventors: Charles E. Sizer (Lincoln, MA); Kurt Olson (Chicago, IL); Susan Gingrich (Hamilton, MA)
Assignee: Cambrooke Therapeutics, Inc.
A61K38/1709A23L2/52A23L2/66A61K31/07A61K31/122A61K31/197A61K31/198A61K31/20A61K31/355A61K31/375A61K31/405A61K31/4172A61K31/4188A61K31/51A61K31/519A61K31/525A61K31/593A61K31/675A61K31/70A61K31/714A23V2002/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,124,036
App. No.
14/738,627
Granted
Nov 13, 2018
Kind
B2
Abstract

Liquid metabolic formulas for dietary management of tyrosinemia, including nutritional formulas and hydration beverages (sport drinks).

Claims (26)

1. A shelf-stable, liquid nutritional formula for dietary management of tyrosinemia comprising:

(a) a protein source that includes:

(i) caseino-glyco-macropeptide (cGMP); and

(ii) complementary amino acids which are a mixture of arginine, tryptophan, leucine, histidine and cysteine, wherein the cGMP is between about 3% and about 6% of the total weight of the formula, and wherein the protein source provides 20-35% of the energy of the nutritional formula;

(b) a fat source which provides 20% to 30% of the energy of the nutritional formula, wherein the fat source is about 1.5% to about 2.2% of the total weight of the nutritional formula;

(c) a carbohydrate source which provides 40% to 60% of the energy of the nutritional formula,

(d) octenyl succinate starch (OSS); and,

(e) a sodium hexametaphosphate-metal (SHMP-metal) mixture comprising SHMP bound to copper and iron,

wherein the nutritional formula contains less than 0.01% by weight of tyrosine.

2. The shelf-stable, liquid nutritional formula of claim 1 , wherein together the complementary amino acids are about 1.5% to about 2.35% of the total weight of the formula.

3. The shelf-stable, liquid nutritional formula of claim 1 , wherein the formula comprises no added tyrosine or phenylalanine.

4. The shelf-stable, liquid nutritional formula of claim 1 , further comprising at least one vitamin and at least one mineral, wherein together the at least one vitamin and the at least one mineral are between about 1.5% and about 2.35% of the total weight of the formula.

5. The shelf-stable, liquid nutritional formula of claim 4 , wherein the at least one mineral is dicalcium phosphate, calcium lactate, dipotassium phosphate, magnesium citrate, sodium ascorbate, zinc sulfate, calcium d-pantothenate, manganese sulfate, potassium iodide, sodium selenite, sodium molybdate, or chromium chloride, and wherein the at least one vitamin is choline bitartrate, ascorbic acid, niacinamide, vitamin E dl-alphatocopheryl acetate, vitamin A palmitate, vitamin B6 pyridoxine, riboflavin, thiamin hydrochloride, folic acid, vitamin K 1 phytonadione, biotin, vitamin D3 cholecalciferol, or vitamin B12 cyanocobalamin.

6. A shelf-stable, liquid nutritional formula for dietary management of tyrosinemia comprising:

(a) a protein source that includes:

(i) caseino-glyco-macropeptide (cGMP); and

(ii) complementary amino acids which are a mixture of arginine, tryptophan, leucine, and histidine;

(b) a fat source, wherein the fat source provides between about 18% to about 27% of the total calories in the formula,

(c) octenyl succinate starch (OSS); and,

(d) a sodium hexametaphosphate-metal (SHMP-metal) mixture comprising SHMP bound to copper and iron,

wherein the protein source provides between about 28% and about 43% of the total calories in the formula, and the formula contains less than 0.01% by weight of tyrosine.

7. The shelf-stable, liquid nutritional formula of claim 6 , wherein the formula comprises no added tyrosine or phenylalanine.

8. The shelf-stable, liquid nutritional formula of claim 6 , further comprising vitamins and additional minerals, wherein the vitamins and additional minerals are present in an amount sufficient to make the formula nutritionally complete.

9. The shelf-stable, liquid nutritional formula of claim 8 , wherein the additional minerals are dicalcium phosphate, calcium lactate, dipotassium phosphate, magnesium citrate, sodium ascorbate, zinc sulfate, calcium d-pantothenate, manganese sulfate, potassium iodide, sodium selenite, sodium molybdate, and chromium chloride, and wherein the vitamins are choline bitartrate, ascorbic acid, niacinamide, vitamin E dl-alphatocopheryl acetate, vitamin A palmitate, vitamin B6 pyridoxine, riboflavin, thiamin hydrochloride, folic acid, vitamin K 1 phytonadione, biotin, vitamin D3 cholecalciferol, and vitamin B12 cyanocobalamin.

10. The shelf-stable, liquid nutritional formula of claim 3 , wherein the formula comprises between about 2.4 mg and about 3.6 mg tyrosine.

11. The shelf stable, liquid nutritional formula of claim 7 , wherein the formula comprises between about 2.4 mg and about 3.6 mg tyrosine.

Assignments (2)
CHANGE OF NAME Recorded Feb 13, 2020
From: CAMBROOKE THERAPEUTICS, INC.
To: AJINOMOTO CAMBROOKE, INC.
Reel/Frame 051928/0502 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 15, 2016
From: SIZER, CHARLES E.; OLSON, KURT; GINGRICH, SUSAN
To: CAMBROOKE THERAPEUTICS, INC.
Reel/Frame 037991/0442 →
Continuity (2)
Related Publication 20160361383A1 · Dec 15, 2016
Related Publication 20180064784A9 · Mar 8, 2018